Optimizing dose and mode of renal replacement therapy in anaemia management

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 5, 2002, Pages 60-65

  Locatelli, Francesco ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Anaemia; Dialysate quality; Dialysis adequacy; Erythropoietin; Membrane; On line treatments

Indexed keywords

CELLULOSE; CYTOKINE; DISINFECTANT AGENT; ION; IRON; PYROGEN; RECOMBINANT ERYTHROPOIETIN; WATER; ERYTHROPOIETIN;

ANEMIA; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DIALYSATE; ERYTHROPOIESIS; HEMODIALYSIS; HEMOFILTRATION; HUMAN; IMMUNE RESPONSE; IRON THERAPY; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MICROBIAL CONTAMINATION; ONLINE SYSTEM; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; WATER QUALITY; WATER TREATMENT; BLOOD; CHRONIC KIDNEY FAILURE; HEMATOCRIT; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ANEMIA; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 0036311999     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_5.60     Document Type: Article

References (37)

1. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients requiring haemodialysis
2. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anemic dialysed uremic patients
3. Clinical practice guidelines for the treatment of anemia of chronic renal failure
4. European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure
5. Is there a role for adjuvant therapy in patients being treated with epoetin?
6. Anemia and carnitine supplementation in hemodialyzed patients
7. Erythropoietin resistance due to dialysate chloramine: The two-way traffic of solutes in haemodialysis
8. Chloramine, a sneaky contaminant of dialysate
9. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil
10. Hemolytic reactions mechanically induced by kinked hemodialysis lines
11. In vitro characterization of the occurrence of hemolysis during extracorporeal blood circulation using a mini hemodialyzer
12. Multistate outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets
13. Multistate outbreak of hemolysis in hemodialysis patients-Nebraska and Maryland, 1998
14. Blood trauma in plastic haemodialysis cannulae
15. Improving anemia by hemodialysis: Effect of serum erythropoietin
16. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
17. Biocompatibility in haemodialysis: Fact and fiction
18. Adequacy of dialysis and differences in hematocrit among dialysis facilities
19. Predictors of target hematocrit among erythropoietin-treated HD patients
20. Hematocrit and erythropoietin dose are associated with dose of dialysis among adult hemodialysis patients: Results from the 1998 ESRD Core Indicators Project
21. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in hemodialysis patients
22. Fluid state and blood pressure control in patients treated with long and short haemodialysis
23. Anaemia and blood pressure correction obtained by daily haemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients
24. Clinical and biochemical correlates of starting 'daily' hemodialysis
25. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
26. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis by continuos ambulatory peritoneal dialysis
27. Removal of high molecular weight substances with large pore size membrane (BK-F)
28. La polisulfona de alta permeabilidad mejora la respuesta, de la anemia a la eritropoyetina en hemodialisis
29. Effect on alleviation of renal anemia by hemodialysis using the high-flux dialyzer (BK-F)
30. Effect of high-flux dialysis on the anemia of haemodialysis patients
31. The impact of hematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity-The experience of the Lombardy Dialysis Registry
32. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters
33. Change from conventional haemodiafiltration to on-line haemodiafiltration
34. Haemodiafiltration with substitution of fluid prepared on-line decreases rHuEPO consumption
35. A comparison of on-line hemodiafiltration and high flux hemodialysis: A prospective clinical study
36. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study
37. Dialysate related cytokine on and response to recombinant human erythropoietin in haemodialysis patients